Diagenode has been selected as the ChIP specialist of the year. This prestigious title was awarded by CiteAb based on the largest number of antibody citations for ChIP/ChIP-seq. Dr Andrew Chalmers, founder of CiteAb sent us a personal note. “Congratulations to Diagenode who are smashing it in the ChIP market. The company’s goal of building products with the highest level of performance is clearly paying off!”
At Diagenode we know how difficult is to find a good quality antibody and how important it is for the success of your assay. As an epigenetics company we develop antibodies specifically against epigenetic targets and validate these antibodies in applications focusing on ChIP and ChIP-seq. Every lot is validated, and only the lots which pass our strict QC is available to customers.
Diagenode’s antibodies are used in labs worldwide. Numerous publications citing our antibodies across a number of scientific journals attest to the fact that the scientific community has carefully chosen Diagenode as a provider of ChIP and ChIP-seq grade antibodies. We remain committed to continuing the development of antibodies of the highest quality for epigenetic applications.
The European Regional Development Fund and Wallonia are investing in your
future.
Extension of industrial buildings and new laboratories.
